| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And President | CEO And President | Director
2 companies
Szela Mary T is a CEO And President at TriSalus Life Sciences, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 8 buys and 1 sell.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | TLSI Trisalus Life Sciences, Inc. | CEO And President | Buy | 10,040 | $5.15 | $51,753.70 | +1.1% | +0.4% | -2.7% | |
| Jan 28, 2025 | TLSI Trisalus Life Sciences, Inc. | CEO And President | Buy | 9,542 | $5.27 | $50,302.84 | +1.1% | +15.1% | -0.4% | |
| Sep 13, 2024 | TLSI Trisalus Life Sciences, Inc. | CEO And President | Buy | 14,815 | $5.09 | $75,358.85 | +1.3% | -12.2% | -2.0% | |
| Sep 10, 2024 | TLSI Trisalus Life Sciences, Inc. | CEO And President | Buy | 5,000 | $4.97 | $24,850.00 | +1.4% | -16.2% | -5.2% | |
| Jun 22, 2020 | CHRS Coherus Oncology, Inc. | Director | Sale+OE | 54,997 | $17.58 | $966,759.26 | -100% | - | - |